FDA validation, genomic data pipelines, and lab integrations. BioTech engineering has a specific skill set — here's what to look for, what to avoid, and the profiles that actually ship.
Biotech software sits at the intersection of two unforgiving domains. Science demands reproducibility and correctness. Regulation demands documentation, traceability, and validation. Generic engineering experience handles neither well — a pipeline that runs cleanly can still produce a wrong biological result, and software that works perfectly can still fail an FDA audit.
Engineers who succeed in biotech are domain-literate: they understand what a variant call means, why reference genome versioning matters, and how a 21 CFR Part 11-compliant audit trail differs from a regular application log. This guide covers the four constraints that define biotech engineering and the five profiles that navigate them.
These aren't edge cases — they're the baseline every biotech engineer works against. Hire profiles that have shipped inside these constraints before.
Software used in regulated biotech environments must be validated — every change documented, every user action auditable, every version controlled with traceability to requirements. This isn't a checkbox at the end of development; it shapes every architectural decision from database schema to deployment pipeline.
Whole-genome sequencing, proteomics, and assay data produce terabytes per run. Processing pipelines must be reproducible, versioned, and computationally efficient — incorrect results in a bioinformatics pipeline don't produce an error, they produce a wrong answer that reaches a lab report.
Lab instruments speak proprietary protocols. LIMS systems are decades old and vendor-locked. Connecting modern software to the physical lab means dealing with HL7, ASTM, or custom TCP/IP APIs that have no documentation and no community of engineers who have shipped against them.
Researchers are expert users with zero tolerance for workflow friction. A UI that doesn't match how a scientist thinks about an experiment — even if it's technically correct — gets abandoned for a spreadsheet. Domain-literate engineers produce tools that scientists actually adopt.
Pre-vetted. LATAM-based. Embedded in your team from day one.
Builds and maintains genomic data pipelines: sequence alignment, variant calling, RNA-seq analysis, and downstream statistical workflows. Writes production code — not just scripts — and understands the difference between a reproducible pipeline and one that produces different results on different machines.
Builds researcher-facing applications, experiment tracking systems, and LIMS integrations. Bridges the gap between scientific requirements and production software — understands both the biology and the engineering well enough to push back on bad requirements.
Structures and curates large scientific datasets for downstream ML. Builds feature engineering pipelines for drug discovery, molecular property prediction, or clinical outcome modeling. Experience with cheminformatics or genomics data is a strong differentiator.
Builds the portals, dashboards, and collaboration tools that research teams use daily — protocol management, sample tracking, data visualization, and report generation. Comfortable working directly with scientists to translate domain workflows into software.
Manages validated computing environments in line with GxP and 21 CFR Part 11 requirements. Change control, audit logging, IQ/OQ/PQ documentation, and cost-efficient HPC infrastructure for computationally intensive workloads. Has worked in an FDA-regulated software context before.
Most biotech engineering failures are predictable. They come from applying generic engineering assumptions to a domain with scientific and regulatory constraints.
21 CFR Part 11 and GxP validation aren't features you add before submission — they're a development methodology. Audit trails, electronic signature controls, and change management procedures must be baked into the architecture from day one. Retrofitting compliance into an existing system routinely costs more than rebuilding it.
Genomics pipelines have correctness requirements that generic data engineering experience doesn't cover: reference genome versioning, tool parameter reproducibility, handling of edge cases in sequencing data, and statistical validity of downstream outputs. A pipeline that runs without errors can still produce scientifically invalid results — and no CI test will catch it.
LIMS vendors do not prioritize API access. Instrument manufacturers use proprietary communication protocols. Data from physical lab systems is inconsistently formatted, timezone-naive, and often incomplete. Engineers without prior experience in this domain routinely underestimate the integration timeline by 3–5x.
Senior engineers from Argentina, embedded in your US team within days.
Meet our engineers